Skip to content
MS
Common carrier Cofactor / common carrier unreviewed

NAD+

0
Pathways
0
Categories
0
As substrate
0
As product

Reactions involving NAD+

Every recorded step where this molecule takes part

Recent literature

Europe PMC · from cache · sorted by publication date

  1. 1
  2. 2
    Sexual rehabilitation across the cystectomy care pathway: pragmatic guidance for multidisciplinary teams; a narrative review.

    Broul M, Hujova A, Liegertova M, Banyrova J, Vostry M, Dadova K. · 2026-06-16

    unreviewed
  3. 3
  4. 4
  5. 5
    Microbiome-driven alterations in tryptophan metabolism contribute to behavioral comorbidities in the Muc2 knockout mouse model of chronic colitis.

    Josephson JK, Barnett JA, Yuzbashian E, Verdugo-Meza A, Murch SJ, Wenzel TJ, Klegeris A, Sharkey KA, Gibson D… · 2026-06-24

    unreviewed
  6. 6
    Effects of dinotefuran and its metabolites on the early life stage development of medaka (<i>Oryzias latipes</i>): <i>In vivo</i> and <i>in silico</i> studies.

    Hirano M, Inoue D, Uchida M, Takahashi K, Kato K, Okobira T, Ishibashi H, Arizono K, Tominaga N. · 2026-06-12

    open access unreviewed
  7. 7
    <i>De novo</i> production of (-)-limonene, (-)-carveol and (-)-carvone via engineering <i>Rhodotorula toruloides</i>.

    Dong Y, Cui S, Du B, Zhang X, Hou J, Lin X, Qin Y, Wang X, Yang X. · 2026-06-13

    open access unreviewed
  8. 8
  9. 9
    Research progress of ferroptosis in gynecological diseases.

    Chen W, Zhou W, Liu S. · 2026-06-19

    open access unreviewed
  10. 10
    The nucleus as a mechanobiological hub in muscle aging.

    Esen O, Battey E, Stroud MJ, Kirby TJ. · 2026-06-18

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.